Tin Mesoporphyrin IX (Chloride): Potent Heme Oxygenase Inhibitor for Advanced Metabolic and Viral Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a nanomolar-affinity, competitive inhibitor of heme oxygenase (HO) enzymes, specifically targeting the catabolism of heme into biliverdin, iron, and carbon monoxide (APExBIO product data). It demonstrates reproducible inhibition of hepatic, renal, and splenic HO activity in vivo at doses as low as 1 pmol/kg, with substantial reductions in serum bilirubin in neonatal hyperbilirubinemia models (Koyaweda et al., 2026). The compound is essential for dissecting heme oxygenase signaling pathways in metabolic disease and viral replication contexts. No clinical trials have been reported; its use is confined to preclinical and translational research (Fam-Azide-5-Isomer overview). The product is supplied as a crystalline solid by APExBIO, with validated solubility and storage stability parameters.

Biological Rationale

Heme oxygenase (HO) is a critical enzyme for heme catabolism, converting heme into biliverdin, iron, and carbon monoxide. The inducible isoform HO-1 is involved in cellular stress responses, metabolic regulation, and immune modulation. Disruption or overactivation of HO-1 signaling has been implicated in conditions such as hyperbilirubinemia, hepatic fibrosis, insulin resistance, and viral pathogenesis, including hepatitis B virus (HBV) infection (Koyaweda et al., 2026). Precise inhibition of HO activity is essential for mechanistic studies in metabolic and infectious disease models. Tin Mesoporphyrin IX (chloride) serves as a benchmark inhibitor to probe the functional and translational roles of heme catabolism in these systems (Phostag Mechanistic Innovation).

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) competitively binds to the active site of heme oxygenase, blocking access to the heme substrate. Its inhibition constant (Ki) is 14 nM, establishing high binding affinity under standard assay conditions (pH 7.4, 37°C, buffer: 50 mM Tris-HCl) (APExBIO). The compound's molecular formula is C34H34Cl2N4O4Sn·2H, and its molecular weight is 754.3 Da. In vitro, it reduces HO-catalyzed conversion of heme to biliverdin and subsequent bilirubin formation as quantified by spectrophotometric or HPLC-based assays. In vivo, administration at 1 pmol/kg inhibits hepatic, renal, and splenic HO activity for extended periods, as measured by decreased tissue biliverdin and serum bilirubin levels (Fam-Azide-5-Isomer). The compound does not interfere with unrelated heme enzymes at recommended concentrations.

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) inhibits HO with a Ki of 14 nM in enzyme activity assays (APExBIO, product page).
• In neonatal animal models, 1 pmol/kg dosing reduces serum bilirubin by >60% within 24 hours (Koyaweda et al., 2026, DOI).
• HO inhibition by Tin Mesoporphyrin IX increases heme saturation of hepatic tryptophan pyrrolase, confirming on-target effect (APExBIO, product page).
• No cytotoxicity or off-target inhibition observed at ≤1 μM in standard cell lines (HEK293, HepG2) (Fam-Azide-5-Isomer, article).
• HO-1 modulation is directly linked to changes in reactive oxygen species (ROS) and viral morphogenesis in HBV models (Koyaweda et al., 2026, DOI).

This article extends the scope of Mechanistic Innovation by providing explicit quantitative assay data and clarifying translational boundaries. It updates Fam-Azide-5-Isomer by integrating new viral pathogenesis evidence from 2026. It also clarifies workflow integration compared to Optimizing Heme Oxygenase Assays by specifying storage and handling parameters for reproducibility.

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is used for the following research purposes:

• Dissecting the heme oxygenase signaling pathway in metabolic disease and metaflammation (APExBIO translational review).
• Validating the role of HO-1 in viral replication, particularly HBV, by modulating ROS and disulfide bond formation (Koyaweda et al., 2026).
• Optimizing heme oxygenase activity assays in cellular and tissue models, with high reproducibility and low off-target risk.
• Serving as a reference inhibitor to benchmark new HO-targeting compounds in pharmacological research.

Common Pitfalls or Misconceptions

• Clinical Use: No clinical trials or approved therapeutic uses; strictly for research (APExBIO).
• Non-specific Inhibition: At recommended concentrations, does not inhibit unrelated heme enzymes, but higher concentrations (>10 μM) may yield off-target effects.
• Solubility: Limited solubility in aqueous buffers; dissolve in DMSO (≤0.5 mg/ml) or DMF (≤1 mg/ml) before dilution.
• Storage: Solutions are unstable at room temperature; store powder at -20°C and use solutions within 24 hours.
• Assay Readouts: Not suitable for direct measurement of ROS; use as an HO inhibitor, not as a ROS probe.

Workflow Integration & Parameters

For optimal results in heme oxygenase activity assays, dissolve Tin Mesoporphyrin IX (chloride) in DMSO or DMF, keeping final DMSO concentrations ≤0.1% in biological assays. Store lyophilized solid at -20°C; avoid repeated freeze-thaw cycles. Use freshly prepared solutions for each experiment. Recommended working range is 1–100 nM for in vitro assays and 1 pmol/kg for in vivo animal models. Monitor HO inhibition by quantifying biliverdin or bilirubin via HPLC or spectrophotometric methods. Include appropriate vehicle and positive controls. The C5606 kit from APExBIO provides validated reference standards and lot-specific quality control (product page).

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) is a gold-standard, potent heme oxygenase inhibitor for metabolic disease and viral pathogenesis research. Its nanomolar affinity, validated performance, and well-characterized limits make it essential for dissecting HO-1-related pathways. Future research may expand its translational applications, but to date, all uses are preclinical. APExBIO continues to provide rigorous quality assurance and documentation for this research tool. For further mechanistic insights and translational strategies, see Strategic Deployment (which provides future-facing experimental guidance beyond the current evidence base).